COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01659047
Brief Title: A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia

First Submitted : August 3, 2012
First Submitted that Met QC Criteria : August 3, 2012
First Posted : August 7, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : September 6, 2012
Last Update Posted : September 7, 2012 (Estimate)